Meylan PR - Search Results

1

Mycobacterium tuberculosis subverts innate immunity to evade specific effectors.

Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR. Loeuillet C, et al. Among authors: meylan pr. J Immunol. 2006 Nov 1;177(9):6245-55. doi: 10.4049/jimmunol.177.9.6245. J Immunol. 2006. PMID: 17056554

2

Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.

Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. Oddo M, et al. Among authors: meylan pr. J Immunol. 1998 Jun 1;160(11):5448-54. J Immunol. 1998. PMID: 9605147

3

Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.

Ciuffi A, Bleiber G, Muñoz M, Martinez R, Loeuillet C, Rehr M, Fischer M, Günthard HF, Oxenius A, Meylan P, Bonhoeffer S, Trono D, Telenti A. Ciuffi A, et al. J Virol. 2004 Oct;78(19):10747-54. doi: 10.1128/JVI.78.19.10747-10754.2004. J Virol. 2004. PMID: 15367641 Free PMC article.

4

The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1.

Meylan PR, Baumgartner M, Ciuffi A, Munoz M, Sahli R. Meylan PR, et al. AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1531-42. doi: 10.1089/aid.1998.14.1531. AIDS Res Hum Retroviruses. 1998. PMID: 9840286

5

Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.

Butticaz C, Ciuffi A, Muñoz M, Thomas J, Bridge A, Pebernard S, Iggo R, Meylan P, Telenti A. Butticaz C, et al. Antivir Ther. 2003 Oct;8(5):373-7. Antivir Ther. 2003. PMID: 14640383

6

Virological and immunological characteristics of HIV treatment failure.

Kaufmann D, Muñoz M, Bleiber G, Fleury S, Lotti B, Martinez R, Pichler W, Meylan P, Telenti A. Kaufmann D, et al. AIDS. 2000 Aug 18;14(12):1767-74. doi: 10.1097/00002030-200008180-00012. AIDS. 2000. PMID: 10985314

7

Interactions of processed Nef (58-206) with virion proteins of HIV type 1.

Ciuffi A, Munoz M, Bleiber G, Favre M, Stutz F, Telenti A, Meylan PR. Ciuffi A, et al. Among authors: meylan pr. AIDS Res Hum Retroviruses. 2004 Apr;20(4):399-407. doi: 10.1089/088922204323048140. AIDS Res Hum Retroviruses. 2004. PMID: 15157358

8

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

Costello E, Munoz M, Buetti E, Meylan PR, Diggelmann H, Thali M. Costello E, et al. Among authors: meylan pr. Gene Ther. 2000 Apr;7(7):596-604. doi: 10.1038/sj.gt.3301135. Gene Ther. 2000. PMID: 10819575 Free article.

9

Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.

Bleiber G, Munoz M, Ciuffi A, Meylan P, Telenti A. Bleiber G, et al. J Virol. 2001 Apr;75(7):3291-300. doi: 10.1128/JVI.75.7.3291-3300.2001. J Virol. 2001. PMID: 11238855 Free PMC article.

10

An adenovirus-based fluorescent reporter vector to identify and isolate HIV-infected cells.

Richman L, Meylan PR, Munoz M, Pinaud S, Mirkovitch J. Richman L, et al. Among authors: meylan pr. J Virol Methods. 2002 Jan;99(1-2):9-21. doi: 10.1016/s0166-0934(01)00375-5. J Virol Methods. 2002. PMID: 11684299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters